Martin cosimo biography

Martin cosimo biography wife.

COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study

  • Research
  • Open access
  • Published:

Thrombosis Journalvolume 16, Article number: 21 (2018) Cite this article

  • 6331 Accesses

  • 20 Citations

  • 13 Altmetric

  • Metrics details

Abstract

Background

Around 20% of venous thromboembolism (VTE) cases occur in patients with cancer.

Cosimo de' medici accomplishments

Current guidelines recommend low molecular weight heparin (LMWH) as the preferred anticoagulant for VTE treatment. However, some guidelines state that vitamin K antagonists (VKAs) and direct oral anticoagulants (DOACs) are acceptable alternatives for long-term therapy in some patients if LMWHs are not available. LMWHs and VKAs have a number of drawbacks that can increase the burden on patients.

DOACs, such as rivaroxaban, can ameliorate some burdens and may offer an opportunity to increase patient satisfaction and health-related quality o